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Abstract
Chronic psychological stress is associated with accelerated aging, but the underlying biological mechanisms are not known.
Prolonged elevations of the stress hormone cortisol is suspected to play a critical role. Through its actions, cortisol may
potentially induce oxidatively generated damage to cellular constituents such as DNA and RNA, a phenomenon which has
been implicated in aging processes. We investigated the relationship between 24 h excretion of urinary cortisol and markers
of oxidatively generated DNA and RNA damage, 8-oxo-7,8-dihydro-29-deoxyguanosine and 8-oxo-7,8-dihydroguanosine, in
a sample of 220 elderly men and women (age 65 – 83 years). We found a robust association between the excretion of
cortisol and the oxidation markers (R
2=0.15, P,0.001 for both markers). Individuals in the highest quartile of cortisol
excretion had a 57% and 61% higher median excretion of the DNA and RNA oxidation marker, respectively, than individuals
in the lowest quartile. The finding adds support to the hypothesis that cortisol-induced damage to DNA/RNA is an
explanatory factor in the complex relation between stress, aging and disease.
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Introduction
Modern biomedical research has shed light on the popular
notion that psychological stress has a negative influence on health
and accelerates aging. Prolonged stress is thought to induce a
‘‘wear and tear’’ syndrome, in which a range of compensatory
physiological mechanisms as well as behavioural changes leads to
negative health influences [1]. For example, it is well established
that chronic stress increases the risk of cardiovascular disease [2].
Stressmayalsohaveatrophiceffectsindistinctareasofthe brain[3],
induce immunosuppression, and contribute to the progression of
some kinds of cancer [4]. Stress-related mental disorders such as de-
pression are associated with an increased non-suicide mortality [5].
The central link between prolonged psychological stress, aging,
and disease, is suspected to be chronic elevations of cortisol and
other stress hormones. Where the acute cortisol response to stress
is necessary for survival, psychological stress associated with
prolonged hypercortisolism supposedly leads to a state of stable
dysregulation that is detrimental to health over time [1]. However,
the underlying molecular mechanisms have yet to be elucidated
[6]. One possibility is that the combined effects of cortisol lead to
increased oxidative stress, in which the mitochondrial production of
reactive oxygen species (ROS) exceeds the antioxidant potential,
thereby causing damage to other molecules such as lipids, proteins
and DNA/RNA. Oxidative stress, in particular the oxidatively
generated damage to DNA, has been suggested to be a central
mediator of aging [7,8].
In animal studies, psychological stress and exogenous cortico-
steroid administration induces increased oxidatively damaged
DNA and other measures of oxidative stress [9–11]. In one study,
oxidatively damaged DNA in rat liver mitochondria increased
after chronic administration of corticosterone (the rodent analog of
cortisol) in a dose-dependent manner [12]. Oxidatively damaged
DNA was increased in clinical studies of occupational stress [13]
and in clinical depression [14].
The oxidation of DNA and RNA generates a range of free
nucleosides, presumably due to the subsequent excision by repair
enzymes. Among these nucleosides, one of the most frequently mea-
sured is 8-oxo-7,8-dihydro-29-deoxyguanosine (8-oxodG), a product
of the oxidation of guanine. 8-oxodG is a marker of total oxidatively
generated DNA damage, and is also a mutagenic lesion in itself [8].
The compound is excreted and measurable in urine [15].
One previous report found a positive correlation between serum
cortisol levels and spot urine sample 8-oxodG concentrations in
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remain significant in multivariate analysis [13]. Due to the high
diurnal variation in cortisol and susceptibility to variation in re-
lation to venipuncture, a 24 h urinary sampling is superior to
blood sampling when estimating overall secretion. Furthermore,
when measuring nucleic acid excretion in spot urine samples, a
correction with urinary creatinine is applied. When using 24 h
samples, this potential confounder is avoided.
In this study, we measured markers of both DNA and RNA
oxidation (8-oxodG and 8-oxo-7,8-dihydroguanosine (8-oxoGuo),
respectively) in 24 h urine samples from a subsample of the
InCHIANTI cohort (Invechiarre in Chianti, aging in the Chianti
Region). We compared the 24 h 8-oxodG and 8-oxoGuo excre-
tion to the excretion of cortisol determined from the same samples.
To our knowledge, the simultaneous determination of urinary
markers of oxidatively generated DNA/RNA damage and cortisol
from a 24 h urine sample has not previously been performed.
Based on the above, we hypothesized a positive association be-
tween 24 h urinary cortisol and 8oxodG/8-oxoGuo excretion.
Results
Demographic, clinical and biochemical characteristics are
shown in Table 1. Linear regression analysis showed significant
positive relationships between both 8-oxodG and 8-oxoGuo and
cortisol excretion (R
2=0.15, P,0.001 for both markers) (Figure
1A). This result persisted after the adjustment for multiple known
or possible confounders of oxidative stress (age, sex, BMI, serum
ferritin, blood glucose, insulin, inflammation status, smoking status
and previous diagnosis of cancer) in multivariate analysis, in which
only serum ferritin (as previously reported [16]) and cortisol were
significantly associated with the oxidation markers (Table 2). Due
to the specific relation between DNA damage and cancer [8], we
ran all analyses without the 22 subjects with a previous diagnosis of
cancer. The association remained highly significant for both 8-
oxodG and 8-oxoGuo, in both linear (P,0.001 for both markers)
and multivariate regression analysis (P=0.002 and P,0.001,
respectively). To further characterise the significance of the as-
sociation, we plotted median 8-oxodG and 8-oxoGuo in relation
to quartiles of cortisol excretion. Individuals in the lowest cortisol
excretion quartile had substantially lower excretion of DNA and
RNA oxidation markers compared to individuals in the highest
quartile (8-oxodG: median=12.49 [interquartile range: 9.03–
14.97] vs 19.65 [14.23–24.55] nmol/24 h, respectively. 8-oxoGuo:
20.23 [15.40–25.33] vs 32.64 [25.23–40.38] nmol/24 h, respec-
tively) (Figure 1B).
Discussion
The result has implications for the accelerated aging and risk for
disease associated with psychological stress states [6]. Depression,
which is very often associated with hypercortisolism [17], has an
increased non-suicide mortality, comparable in size to the excess
mortality associated with smoking [5,18]. Perceived psychological
stress in mothers giving care to chronically ill children was asso-
ciated with shortened telomeres, which is a proposed measure of
biological age [19]. Similar results have been obtained in adult
persons with childhood adversities as well as in anxiety, mood
disorder, and schizophrenia patients [20–22].
It has been suggested that these pro-aging effects of stress are
mediated by hormonal changes, in particular the prolonged
elevation of cortisol [6]. The cardiovascular comorbidity of stress
and depression is high [2,5], and hypercortisolemic depression has
been shown to be associated with the metabolic syndrome [23].
Furthermore, it was recently demonstrated that higher urinary
cortisol excretion in itself is a predictor of cardiovascular mortality
[24]. However, it should be noted that not all psychological stress
is associated with hypercortisolism. Stress states such as PTSD
have been associated with hypocortisolism, and this has even been
hypothesized to have protective somatic effects [25].
Here we provide evidence for a robust association between
cortisol excretion and the amount of oxidatively induced damage
to DNA and RNA. The increase in DNA/RNA oxidation marker
excretion with increased cortisol excretion (i.e. being in either the
upper vs. the lower quartile of cortisol excretion) is comparable to,
if not exceeding, the increase observed in smoking [26], a leading
age-advancing factor [27].
Genotoxic stress such as DNA damage is suspected to be a
major contributor to the aging process [7]. The oxidatively
generated damage to DNA accumulates with age and can cause
single and double strand breaks, which may lead to cell senes-
cence, mutagenesis or apoptosis [8]. Animals and humans with
genetic defects in nuclear DNA repair phenotypically display
premature aging [28]. Oxidatively induced damage to telomeres
Table 1. Demographical, clinical and biochemical characteristics
of the cohort.
Medical history
Previous diagnosis of cancer 22/211 (10%)
Cancer diagnosis last 10 years 8/211 (4%)
Diabetes 11/209 (5%)
Chronic bronchitis 2/209 (1%)
Bronchial asthma 0/209 (0%)
Emphysema 5/209 (2%)
CHF 6/209 (3%)
Parkinson’s disease 2/209 (1%)
Hypertension 19/208 (9%)
Angina pectoris 8/209 (4%)
Stroke 6/209 (3%)
Myocardial infarction 4/209 (2%)









Male sex 108 (51%)
Laboratory variables
Serum creatinine (mg/dL) 0.9 (0.8–1.0)
Cholesterol total (mg/dL) 221.0638.4
Triglycerides (mg/dL) 109 (81–151)
HS-CRP (mg/mL) 2.20 (0.97–8.62)
IL-6 (pg/mL) 1.03 (0.63–3.23)
Systolic blood pressure (mmHg) 150 (130–160)
Diastolic blood pressure (mmHg) 80 (80–90)
Footnote: The total number of subjects in each disease category varies due to
missing data. Laboratory variables are given as median (interquartile range) or
mean 6 standard deviation.
doi:10.1371/journal.pone.0020795.t001
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Therefore, an association between cortisol and 8-oxodG/8-oxo-
Guo could be of importance to the link between stress, aging and
age-related disease. Since genomic damage may cause mutations
that can lead to cancer, it could also be expected from this
association that stress increases the risk for malignant disease.
However, while stress might have a promoting effect on existing
cancers, there is no clinical evidence to suggest that stress increase
cancer risk per se [4].
There are several possible mechanisms that could account for
the presented association. Cortisol is released from the adrenal
glands by activation of the hypothalamic-pituitary-adrenal (HPA)
axis in response to psychological stress, as well as to a variety
of physiological challenges. The hormone binds to intracellular
glucocorticoid receptors, and exerts its effects by altering gene
expression [31]. Hence, one could speculate that oxidative stress
effects are mediated by transcriptionally determined changes in
DNA/RNA repair, antioxidant defence systems and/or ROS
formation. In fact, in an in vitro study using murine fibroblasts,
corticosteroids (as well as catecholamines) were shown to induce
DNA damage (as measured by the comet assay), decrease DNA
repair and modulate the expression of several genes involved
in DNA damage responses [32]. Corticosteroid treatment and
chronic ‘‘restraint stress’’ have been shown to reduce antioxidant
defenses in the brain, liver and heart of rats [11]. Finally, long-
term corticosteroid treatment negatively influences various
measures of mitochondrial function (oxidation, membrane poten-
tial and calcium holding capacity) [33], and thus could also be
suspected to induce increased leakage of ROS during mitochon-
drial respiration, although this has never, to our knowledge, been
directly investigated.
The net result of these diverse effects is likely to be a general
increase in oxidative damage to DNA and RNA. The above-
mentioned finding of a dose-dependent increase in hepatic mito-
chondrial DNA oxidation after corticosterone treatment is in line
with this notion [12]. Experimental induction of oxidative DNA
Figure 1. 24 h urinary excretion of cortisol vs markers of nucleic acid oxidation. A: Scatterplot of log-transformed 8-oxodG and 8-oxoGuo
values vs 24 h cortisol excretion. B: Median nucleic acid excretion vs quartiles of cortisol excretion. Median 8-oxodG and 8-oxoGuo is 57% and 61%
percent higher, respectively, in individuals in the highest vs individuals in the lowest cortisol excretion quartile.
doi:10.1371/journal.pone.0020795.g001
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excretion of 8-oxodG [34]. Hence, a general increase in whole-
body nucleic acid oxidation caused by higher cortisol levels would
most likely also entail increased urinary excretion of DNA/RNA
oxidation markers.
The level of cortisol excretion was correlated with both DNA
and RNA oxidation. DNA is stable and primarily present in the
nucleus of cells, whereas RNA has a rapid turn-over and is present
primarily outside the nucleus. The two nucleic acid oxidation
markers were highly correlated [16]. This would indicate that high
cortisol can lead to oxidative modifications of different molecules
in different parts of cells, and thus a general state of oxidative stress
rather than DNA or RNA oxidation specifically. Accumulating
evidence suggest that RNA damage may play an important role in
human pathophysiology by interfering with mRNA translation
and thereby protein expression [35,36].
It should be firmly emphasized, however, that the present
results are correlational, and therefore do not allow for any
conclusions on the biological events that link cortisol and 8-
oxodG/8-oxoGuo excretion to each other. Cortisol secretion
might be associated with other stress-related hormonal changes,
which can also lead to oxidative stress (e.g catecholamines).
Furthermore, it is possible that individuals with high oxidative
stress due to other conditions concomitantly have an increased
HPA-axis activity. However, the fact that the cohort was gen-
erally healthy, and that the analysis was robust for the adjustment
for multiple known or possible confounders of oxidative stress,
indicates that this is not the case in our study. Our findings are
based on a cross-sectional investigation of a cohort of elderly
individuals, and cannot necessarily be extended to younger
persons. HPA-axis activity is exaggerated in the elderly [37], and
antioxidant defences may be impaired [38]. This combination
entails that the association between cortisol and oxidative stress
could be stronger – and thus perhaps more readily uncovered - in
the elderly than in younger individuals.
It is not possible to establish the anatomical origin of the urinary
markers, and importantly, some tissues may contribute more than
others. The brain, for example, has a high glucocorticoid sensi-
tivity, a large oxygen consumption per mass tissue and relatively
modest antioxidant defence [31,39], and therefore may be
particularly prone to cortisol-induced oxidative stress. This specific
vulnerability of the brain is supported by evidence suggesting an
important role of oxidative stress in the pathogenesis of neu-
rodegenerative disorders, including Alzheimer’s disease [39,40]. In
that context, it is notable that depression appears to increase the
risk of dementia in a dose-response manner (i.e. risk increasing
with the number of depressive episodes) [41,42].
The urinary excretion of oxidized nucleosides is widely con-
sidered to reflect the rate of whole body DNA/RNA oxidation.
That said, the exact origins of these urinary markers are not de-
termined, and several repair enzymes have been implicated [43].
In principle, these could be differentially regulated by cortisol,
influencing the formation of free oxidized nucleosides in unpre-
dictable ways. However, we would argue that in most in vivo
situations, enzymatic repair activity will follow first order kinetics
and thereby the amount of oxidation, meaning that inter- or
intraindividual differences in urinary excretion of 8-oxodG/8-
oxoGuo do in fact reflect differences in oxidative stress on DNA/
RNA, rather than differences in repair activity [44].
The study was based on a subsample of the InChianti cohort,
which was originally selected for another study, namely the
association between low-grade inflammation and oxidative nucleic
acid oxidation (see ‘‘Methods’’). Somewhat surprisingly, we did not
find evidence to support such an association. This has been
discussed elsewhere [16]. There was no difference in either cortisol
or 8-oxodG/8-oxoGuo excretion in the low-grade vs no inflam-
mation group, and no difference in cortisol excretion between the
subsample and the entire cohort. We can not rule out that
differences in cellular glucocorticoid sensitivity or diurnal cortisol
rythm, which is not detected by the 24 h excretion of cortisol,
could exist between the inflammation groups. Gene expression
studies using peripheral blood monocytes has suggested that stress
associated with caregiving may reduce cellular glucocorticoid
sensitivity, and increase the expression of pro-inflammatory factors
such as NF-kb, in the absence of increased salivary cortisol
secretion [45]. However, such potential differences in our groups
have not resulted in differing 8-oxodG/8-oxoGuo excretion. Fur-
thermore, there was no effect on the result when adjusting for
inflammation status. Based on this, we consider the subsample to
be applicable for the present study.
Table 2. Multivariate regression analysis.
log 8-oxodG log 8-oxoGuo
b SE Partial R
2 P Adjusted R
2 b SE Partial R
2 P Adjusted R
2
Model ,0.0001 0.3041 ,0.0001 0.2156
Cortisol 0.0031 0.0007 0.1067 ,0.0001 0.0026 0.0007 0.0945 ,0.0001
Ferritin 0.0013 0.0002 0.1950 ,0.0001 0.0009 0.0002 0.1086 ,0.0001
Age 20.0068 0.0065 0.0064 0.2983 0.0008 0.0062 0.0001 0.9824
Sex 0.0308 0.0650 0.0064 0.6357 20.0076 0.0629 ,0.0001 0.9041
Body Mass Index 20.0033 0.0068 0.0014 0.6255 0.0067 0.0064 0.0070 0.4256
Glucose 20.0006 0.0013 0.0015 0.6111 0.0022 0.0012 0.0236 0.0562
Insulin 0.0019 0.0050 0.0009 0.7011 0.0061 0.0051 0.0093 0.2328
Inflammation status
a 20.0790 0.0585 0.0108 0.1785 20.0031 0.0558 ,0.0001 0.9558
Smoking status
b 20.0701 0.0634 0.0072 0.2700 20.0489 0.0612 0.0042 0.4256
Cancer status
c 0.1727 0.0980 0.0182 0.0799 20.0334 0.0937 0.0008 0.7221
Footnote: b=regression coefficient. SE = standard error. R
2= coefficient of determination.
a ‘‘Low-grade inflammation’’ or ‘‘no inflammation’’.
b Smoker or non-smoker.
c 6 previous diagnosis of cancer.
doi:10.1371/journal.pone.0020795.t002
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excretion of cortisol and markers of oxidatively generated DNA
and RNA damage in a population of elderly individuals, which
persisted after the adjustement for multiple confounders of
oxidative stress. Although causality cannot be inferred from this
cross-sectional study, the suggestion of a causal relationship is
strengtened by experimental interventions showing induction of
oxidatively generated DNA damage by corticosterone in vivo [12],
as well as by plausible biological mechanisms demonstrated in vitro
[32,33]. The finding adds support to the hypothesis that cortisol-
induced damage to DNA/RNA is an explanatory factor in the
complex relation between stress, aging and disease. Further studies
on the association are needed, e.g. animal and in vitro studies,
which would allow for interventions that could shed more light on
the potential causal mechanisms involved.
Materials and Methods
Ethics Statement
The Italian National Institute of Research and Care on Aging
Ethical Committee approved the study protocol, which complied
with the principles stated in the Declaration of Helsinki.
Cohort
InCHIANTI is an epidemiological study of risk factors con-
tributing to the declining ability to walk in late life. The study was
performed in two small towns located in Tuscany (Italy): Greve in
Chianti and Bagno a Ripoli, between September 1998 and April
2000. The design and data collection methods of InCHIANTI are
described in detail elsewhere [46]. The study population consisted
of a random sample of the population aged 65 years and older
selected from the city registry of the two municipalities, and an
additional small sample of younger people. Of the 1530 subjects
originally sampled, 1453 agreed to participate in the study. Par-
ticipants received an extensive description of the study and parti-
cipated after providing written informed consent.
The subsample (n=220) was initially selected from the upper
and lower tertiles of selected markers of inflammation (CRP and
IL-6), to study whether low-grade inflammation was associated
with increased nucleic acid oxidation [16]. The subsample
included subjects between 65 and 83 years of age. 110 ‘‘low-
grade inflammation’’ cases were selected from the top tertile of
both serum CRP (median =8.62 [interquartile range =5.68 -
14.10] mg/ml) and IL-6 (3.22 [2.31–4.88] pg/ml) and were
matched by age and sex with 110 ‘‘no-inflammation’’ controls
found in the lowest tertile of CRP and IL-6 (0.97 [0.62–1.27] mg/
ml and 0.63 [0.46–0.82] pg/ml, respectively). In nine subjects the
remaining urine volume was insufficient for analysis. There was no
difference in urinary cortisol excretion between cases and controls
(98.2 [68.1–124.7] mg and 104.6 [72.9–126.0] mg respectively,
p=0.48). There was no difference between urinary cortisol
excretion in the subsample vs the entire cohort (100.8 [70.0 –
125.8] mg and 95.3 [70.3 – 124.3] mg respectively, p=0.52).
Determination of cortisol, 8-oxodG and 8-oxoGuo
Before an in-clinic assessment, study participants collected all
urine produced during a 24 h period starting after the first voided
urine following awakening and including the first voided urine on
the following day. At assessment, 10 ml aliquots of urine were
prepared and stored at –80uC for later assaying at the Clinical
Chemistry Laboratory of the Careggi Hospital, Italy. Complete-
ness of urine collection was evaluated using 24-h urinary creat-
inine excretion. Subjects with urinary creatinine level ,6 mmol/
day plus total urine volume ,1000 L/day or with a urinary
creatinine level ,5 mmol/day were identified as having incom-
plete urine collection [47]. Urinary cortisol was measured by an
immunochemiluminescence method and an ADVIA-Centaur
immunoassay system (Bayer Diagnostics). The intra-assay coeffi-
cient of variation was less than 2.0% and the inter-assay coefficient
of variation was less than 3.0%. Urinary cortisol excretion was
defined as mg of cortisol excreted over 24 h [23].
The same samples were assayed for the oxidatively modified
nucleosides 8-oxodG and 8-oxoGuo using high-performance
liquid chromatography-tandem mass spectrometry (HPLC MS/
MS) at the Department of Clinical Pharmacology, Rigshospitalet,
Denmark. Urinary 8-oxodG is stable for at least 15 years when
stored at -20 degrees celcius [48]. Chromatographic separation
was performed on a Perkin Elmer Series 200 HPLC equipped with
two pumps, autosampler, solvent cabinet and vacuum degasser
(Perkin Elmer, Norwalk, CT, United States). The column used
was a Phenomenex Prodigy ODS HPLC column (10062 mm,
3 m) protected with a C18 (ODS) guard column (462 mm), both
obtained from Phenomenex (Torrance, CA, United States). The
mass spectrometric detection was performed on an API 3000 triple
quadrupole mass spectrometer (Sciex, Toronto, Canada) equipped
with a turboionspray source (Turbospray). Details of the analysis
are described elsewhere [15]. Urinary excretion of 8-oxodG and 8-
oxoGuo was defined as nmol excreted over 24 h.
Statistics
Simple and multivariate linear regression analyses were used to
determine the association between urinary cortisol excretion and
urinary 8-oxodG and 8-oxoGuo excretion. One extreme outlier
was omitted (cortisol value both outside the 99
th percentile of the
data and above the upper normal limit for 24 h cortisol excretion
of 350 nmol/24 h). Due to deviation from normal distribution the
variables 8-oxodG and 8-oxoGuo were log-transformed before
calculation, which resulted in normal distribution of both vari-
ables. To determine differences between the subsample and the
entire InChianti cohort, and between the high and low inflam-
mation groups in the subsample, variables were tested using
Wilcoxon signed-rank test. All statistical analyses were performed
using the SAS software version 9.1 (SAS Institute Inc. Cary, NC,
USA). Statistical significance was defined as P,0.05. All statistical
tests were two sided.
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